Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver di

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:Lossed
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To evaluate the potential of S-nitroso-N-acetylcysteine (SNAC) in inhibition of lipid peroxidation and the effect of oral SNAC administration in the prevention of nonalcoholic fatty liver disease (NAFLD) in an animal model.METHODS: NAFLD was induced in Wistar male rats by choline-deficient diet for 4 wk. SNAC-treated animals (n=6) (1.4 mg/kg/day of SNAC, orally) were compared to 2 control groups: one (n=6) received PBS solution and the other (n=6) received NAC solution (7 mg/kg/d).Histological variables were semiquantitated with respect to macro and microvacuolar fat changes, its zonal distribution, foci of necrosis, portal and perivenular fibrosis, and inflammatory infiltrate with zonal distribution.LOOHs from samples of liver homogenates were quantified by HPLC. Nitrate levels in plasma of portal vein were assessed by chemiluminescence. Aqueous low-density lipoprotein (LDL) suspensions (200 μg protein/mL) were incubated with CuCl2 (300 μmol/L) in the absence and presence of SNAC (300 μmol/L) for 15 h at 37 ℃. Extent of LDL oxidation was assessed by fluorimetry. Linoleic acid (LA) (18.8 μmol/L) oxidation was induced by soybean lipoxygenase (SLO) (0.056 μmol/L) at 37 ℃ in the presence and absence of N-acetylcysteine (NAC) and SNAC (56 and 560 μmol/L) and monitored at 234 nm.RESULTS: Animals in the control group developed moderate macro and microvesicular fatty changes in periportal area. SNAC-treated animals displayed only discrete histological alterations with absence of fatty changes and did not develop liver steatosis. The absence of NAFLD in the SNAC-treated group was positively correlated with a decrease in the concentration of LOOH in liver homogenate, compared to the control group (0.7±0.2 nmol/mg vs 3.2±0.4 nmol/mg protein, respectively, P<0.05), while serum levels of aminotransferases were unaltered. The ability of SNAC in preventing lipid peroxidation was confirmed in in vitro experiments using LA and LDL as model substrates.CONCLUSION: Oral administration of SNAC prevents the onset of NAFLD in Wistar rats fed with cholinedeficient diet. This effect is correlated with the ability of SNAC to block the propagation of lipid peroxidation in vitro andin vitro.
其他文献
目的比较飞秒激光小切口角膜基质透镜取出术(SMILE)与有晶状体眼后房型人工晶状体植入术(ICL)矫正高度近视的效果。方法回顾性分析近视屈光度为-8.00 D~-10.00 D者76例(152只眼),其中40例(80只眼)接受SMILE术,36例(72只眼)行ICL V4c植入术,对两组术后视力、高阶像差均方根值和对比敏感度进行比较分析。结果术后1、3、6和12个月裸眼视力、最佳矫正视力及残留屈光
通过整理近年来鹰爪花属植物相关文献发现,该属植物主要有生物碱类、萜类、木脂素类以及黄酮类等多种化学成分,具有抗肿瘤、抗菌、抗疟、抗病毒等生物活性,目前应用于医药卫
期刊
@@
目的:分析腹膜透析专业护理门诊对患者透析治疗的影响效果.方法:本次研究时间为2016年8月~2017年8月,涉及的患者研究人员共计80例,对上述患者进行腹膜透析专业护理门诊,分析干
1例42岁女性患者三尖瓣置换术后为预防血栓服用华法林(3.00 mg/d).用药第3天查凝血酶原时间(PT)15.5 s,国际标准化比值(INR) 1.3,将华法林调整为3.75 mg/d.第8天患者出现心房
目的探讨糖耐量异常患者凝血功能变化及二甲双胍的干预效应。方法将100例糖耐量异常患者按照随机数字表法分为试验1组和试验2组,每组50例,另选择健康志愿者50例作为对照组。试验2组给予二甲双胍治疗,试验1组给予安慰剂治疗。治疗前后各组行口服葡萄糖耐量试验(OGTT),检测糖负荷后2 h血糖(2 h PBG),并检测糖化血红蛋白以及凝血酶原时间(PT)、活化部分凝血活酶时间(APTT )、凝血酶时间(
目的观察糖尿病性视网膜病变(DR)患者视网膜中央血管血流动力学参数的改变。方法对不合并DR的糖尿病66例(117只眼,DM组)、DR 98例(181只眼,DR组)和老年性白内障或屈光不正68例(136只眼,对照组)进行前瞻性病例对照研究。结果分析三组患者视网膜中央动脉直径(P=0.000)和血流速度(P=0.000)、视网膜中央静脉血流速度(P=0.000)、搏动指数(P=0.025)、阻力指数(
目的探讨背阔肌皮瓣修复肘部严重软组织缺损的效果。方法17例肘部严重软组织缺损患者采用背阔肌皮瓣治疗,10例行功能重建型肌皮瓣转移,其中重建屈肘9例,重建伸肘1例;7例行创面覆盖型肌皮瓣,肌皮瓣面积6 cm×10 cm~ 12 cm×27 cm。结果所有肌皮瓣完全成活,术后随访12~ 40(22.0±9.6)个月,皮瓣色泽、质地良好,肘部无瘢痕挛缩,外形不臃肿,功能重建型皮瓣修复10例,肘关节屈曲1
The enantiomers separation of thirteen drugs collected in Ch.P2010 was performed on chiral stationary phase of cellulose ramification (chiralpak OD and chiralpa